Precision Medicine Software Market forecast 10% CAGR with government initiatives and VC funding 2026
The global
precision medicine software market is anticipated to witness
a CAGR of 10% by 2026, driven by the growing research in the
segment of genomics/precision medicine, significant VC funding, rising
government support, and the rapid move towards personalized treatments.
Precision medicine, sometimes known as "personalized
medicine" is an innovative approach to tailoring disease prevention and
treatment based on the individual’s unique characteristics and genetic make-up.
Precision medicine software (platforms, data-sharing networks, clinical
decision support software, AI-enabled, etc.) provides the healthcare/life
sciences community with integrated data and data-driven insights to strengthen
their precision medicine program.
🔗 Want deeper insights?
Download the sample report:
https://meditechinsights.com/precision-medicine-software-market/request-sample/
The Shift from the Dominant One-Size-Fits-All Approach to
Personalized Care
The precision medicine approach promises better clinical
outcomes, safer medicines, and less wastage/cost savings. With the increasing
demand to provide value to healthcare systems, drug developers have started to
move away from the traditional one-size-fits-all approach to the personalized
care approach.
In 2020, the FDA approved 20 personalized drugs and
biologics (39% of the new approvals). Precision medicines accounted for a
quarter or more of all new drugs approved by the FDA each year in the past five
years. With the growing interest and increasing opportunities in precision
medicine, the demand for precision medicine software is also anticipated to
grow.
Favorable Government Initiatives
Realizing the long-term benefits of personalized care in
improving population health and reducing healthcare costs, governments across
the globe are supporting advanced treatments like precision medicine through
initiatives, regulatory changes, and/or funding research. For instance, in the
US, The Oncology Care Model, a specialty payment and delivery model developed
by the CMS Innovation Center is providing incentives that have led to a surge
of large community provider networks implementing precision medicine
initiatives. Some of the other programs to advance the research/use of
precision medicine include The Precision Medicine Initiative (PMI), All of Us
Research Program, precisionFDA, and Million Veteran Program. In addition, FDA
issued seven guidance documents in 2020 related to precision medicine. All
these efforts would eventually boost the demand for precision medicine
software.
Vast Growth Opportunities in Oncology
Precision medicine holds great promise for reshaping the way
cancer is treated. The increasing prevalence of cancer and growing funding for
cancer research would propel the adoption of precision medicine in oncology.
High-quality patient datasets are the foundation to bring precision oncology
into clinical practice. Thus, providing great opportunities for precision
oncology software providers. Some of the recent activities in this space
include:
- In
Apr 2022, BostonGene, a precision cancer software start-up raised $150
million Series B funding.
- In
Nov 2021, GE Healthcare announced collaborations with SOPHiA GENETICS, The
University of Cambridge and Optellum as part of its vision to advance
care, make precision health more accessible, and ultimately improve
outcomes for cancer patients.
- In
Feb 2021, Synapse, a provider of software to support precision oncology
care and drug discovery closed a $68 million growth equity investment
round to expand in RWE-driven precision medicine.
Key Challenges in Precision Medicine Software Market
For the emergence of precision medicine in every disease
area, the industry needs to know how to optimize the use of big data with the
increase in the amount of genomics, health, and lifestyle information.
Further, the high cost of deployment, issues related to the
secure storage of large volumes of sequenced data, lack of reimbursement for
precision medicine-based treatments, and the shortage of expert
technicians/bioinformaticians are some of the key challenges faced in precision
medicine software market.
Gain a competitive edge-request a sample report now!
https://meditechinsights.com/precision-medicine-software-market/request-sample/
Competitive Landscape Analysis: Precision Medicine
Software Market
The global precision medicine software market is highly
competitive and fragmented. Some of the key/promising players in this market
include Syapse, Fabric Genomics, Sophia Genetics, 2bprecise, PierianDx, Inc.,
PhenoTips, Foundation Medicine, Inc., GenomOncology, LLC, Translational
Software, Inc., LifeOmic Health, LLC, Sunquest Information Systems, Inc.,
Tempus, Human Longevity, Inc., and N-of-One Inc.
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research combined
with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply
side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment